| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/02/2006 | EP1685157A2 Novel therapeutic targets in cancer |
| 08/02/2006 | EP1685152A2 Il-18 binding proteins |
| 08/02/2006 | EP1684869A2 Methods of therapy for b cell-related cancers |
| 08/02/2006 | EP1684805A2 Use of antagonist anti-cd40 monoclonal antibodies for treatment of multiple myeloma |
| 08/02/2006 | EP1684804A2 Binding molecules for the extra-domain b of fibronectin, used for the detection of atherosclerotic plaques |
| 08/02/2006 | EP1684803A2 Immune modulator comprising whole cell rhodococcus, gordonia, nocardia, dietzia, tsukamurella or nocrdioides bacteria |
| 08/02/2006 | EP1684802A2 Immunogenic compositions |
| 08/02/2006 | EP1684801A1 Recombinant adenylate cyclase toxin of bordetella induces t cell responses against tumoral antigens |
| 08/02/2006 | EP1684800A2 In vivo efficacy of ny-eso-1 plus adjuvant |
| 08/02/2006 | EP1684799A2 Rescue agents for treating botulinum toxin intoxications |
| 08/02/2006 | EP1684798A2 Recombinant intracellular pathogen immunogenic compositions and methods for use |
| 08/02/2006 | EP1684797A1 Vaccine and method for treatment of neurodegenerative diseases |
| 08/02/2006 | EP1684796A2 Methods for modulating the th2 immuneresponse to an antigen by adding or removing activated carbonyl groups from the antigen |
| 08/02/2006 | EP1684791A2 Compositions and methods to modulate an immune response to an immunogenic therapeutic agent |
| 08/02/2006 | EP1684790A2 Homogeneous preparations of chimeric proteins |
| 08/02/2006 | EP1684785A2 B cell-targeted toxins for humoral immune response reduction |
| 08/02/2006 | EP1684770A1 Oligo-beta-(1,3)-glucan and monoclonal antibodies against cancer |
| 08/02/2006 | EP1684703A2 Methods and compositions for treating mcp-1 related pathologies |
| 08/02/2006 | EP1440149B1 Use of an infectious and attenuated type ii bovine viral diarrhea virus clone to prevent foetal infection by type i bvdv |
| 08/02/2006 | EP1420815B1 Beta-amyloid-analogue - t-cell epitop vaccine |
| 08/02/2006 | EP1345694B1 A method for the manufacture of compositions containing low concentrations of salts |
| 08/02/2006 | EP1265598B1 Pharmaceutical composition for application to mucosal surfaces |
| 08/02/2006 | EP1246616B1 Cell permeable peptides for inhibition of inflammatory reactions and methods of use |
| 08/02/2006 | EP1224460B1 Cell proliferation diagnosis and screening for modulators |
| 08/02/2006 | EP1196560B1 Neurotrophic factor receptor gfr-alpha-4 |
| 08/02/2006 | EP1058562B1 Compositions and methods of treating tumors |
| 08/02/2006 | EP1056878B1 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant virus |
| 08/02/2006 | EP0979243B1 Activation of peptides |
| 08/02/2006 | EP0975360B1 Bovine respiratory and enteric coronovirus as a vaccine |
| 08/02/2006 | EP0914339B1 RET LIGAND 3 (RetL3) FOR STIMULATING NEURAL AND RENAL GROWTH |
| 08/02/2006 | EP0751962B1 Methods for inhibiting cd14 mediated cell activation |
| 08/02/2006 | CN1813188A Diagnosis of carcinomas |
| 08/02/2006 | CN1813061A Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus |
| 08/02/2006 | CN1812999A Pharmaceutical composition comprising a bispecific antibody specific for EpCAM |
| 08/02/2006 | CN1812810A Materials and methods for immunizing against fiv infection. |
| 08/02/2006 | CN1812809A Immunogenic compositions for chlamydia trachomatis |
| 08/02/2006 | CN1812806A Tissue protective cytokine receptor complex, assays for identifying tissue protective compounds and uses thereof |
| 08/02/2006 | CN1812803A Human mast cell-expressed membrane protein |
| 08/02/2006 | CN1812799A Pharmaceutical composition for improved administration of HIV gp41-derived peptides,And its use in therapy |
| 08/02/2006 | CN1810970A CpG-containing single-stranded deoxynucleotide, its vaccine composition and their application |
| 08/02/2006 | CN1810969A Method of obtaining protein segment with independent structure/function |
| 08/02/2006 | CN1810961A Recombinant influenza virus and its prepn and application |
| 08/02/2006 | CN1810833A Molecular design and prepn process of recombinant polyepitope chimeric peptide CP22 antigen of human chorionic gonadotropin |
| 08/02/2006 | CN1810292A Protein purification by ion exchange chromatography |
| 08/02/2006 | CN1810291A Nasal cavity spraying inactivated influenza virus vaccine and its prepn process |
| 08/02/2006 | CN1267553C Haemophilus transferrin receptor genes |
| 08/02/2006 | CN1267550C Vascular endothelial growth factor 2 |
| 08/02/2006 | CN1267452C Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases |
| 08/02/2006 | CN1267153C A and O type gene engineering bivalent polypeptide vaccine of livestock foot-and-mouth disease virus and its preparation process |
| 08/01/2006 | US7084266 Cloned genome of infectious hepatitus C virus of genotype 2A and uses thereof |
| 08/01/2006 | US7084259 G-protein coupled receptors |
| 08/01/2006 | US7084249 Tumor associated antigen peptides and use of same as anti-tumor vaccines |
| 08/01/2006 | US7084247 Identification of self and non-self antigens implicated in autoimmune diseases |
| 08/01/2006 | US7083969 Serratia marcescens strain |
| 08/01/2006 | US7083959 Constructs size fractionated to homogeneity; does not elicit an immune response to said moieties but does directly compete with said antigen for receptors on an immunocompetent cell that recognizes said determinant. |
| 08/01/2006 | US7083957 Modified proteins, designer toxins, and methods of making thereof |
| 08/01/2006 | US7083943 Polynucleotides related to murine anti-idiotype antibody 11D10 and methods of use thereof |
| 08/01/2006 | US7083934 Method for detecting transferrin receptor-like proteins |
| 08/01/2006 | US7083927 Comprises nucleotide sequences coding ubiquitin protein ligase complex polypeptides for diagnosid and treatment of cancer, immune/inflammatory and neurological disorders |
| 08/01/2006 | US7083814 Antiviral substances from plant cuticular and epicuticular material |
| 08/01/2006 | US7083798 Method of immunomodulatory treatment of insulin dependent diabetes mellitus using mycobacterial cell wall compositions |
| 08/01/2006 | US7083797 32-kDa protein derived from Mycobacterium tuberculosis and related peptides |
| 08/01/2006 | US7083796 Fusion proteins of mycobacterium tuberculosis |
| 08/01/2006 | US7083795 Inactivated respiratory syncytial viral vaccines |
| 08/01/2006 | US7083794 Selecting for a strain of bacteria having an RpoS+ phenotype, inactivating mutations which render the strain attenutated, and a recombinant gene encoding the product |
| 08/01/2006 | US7083793 Coding Mycobacterium tuberculosis; isolation protein |
| 08/01/2006 | US7083792 Immunologically active proteins from Borrelia burgdorferi |
| 08/01/2006 | US7083790 Extracellular serine protease |
| 08/01/2006 | US7083789 Polynucleotides; induce lymphocyte response |
| 08/01/2006 | US7083787 Induce immunology response; administering yeast vehicle and antigen |
| 08/01/2006 | US7083786 Mannan binding lectin-associated serine protease-2; serine protease that acts in the MBLectin complement fixation pathway |
| 08/01/2006 | US7083785 Tumor necrosis factor family and its blocking agent |
| 08/01/2006 | US7083784 Molecules with extended half-lives, compositions and uses thereof |
| 08/01/2006 | CA2250714C Animal cells and processes for the replication of influenza viruses |
| 08/01/2006 | CA2165435C Isolated peptides which form complexes with mhc molecule hla-c-clone 10 and uses thereof |
| 07/29/2006 | WO2006078680A2 Polypeptides for inducing a protective immune response against staphylococcus aureus |
| 07/27/2006 | WO2006078975A2 Improved vaccine against feline calicivirus |
| 07/27/2006 | WO2006078780A2 Rdc1 antibodies for the diagnosis of nsclc |
| 07/27/2006 | WO2006078717A2 Lipocalin 2 for the treatment, prevention, and management of cancer metastasis, angiogenesis, and fibrosis |
| 07/27/2006 | WO2006078648A2 Rhinovirus vaccines |
| 07/27/2006 | WO2006078368A1 Methods for the production of ansamitocins |
| 07/27/2006 | WO2006078336A2 Compositions and methods for the treatment and prevention of hyperproliferative diseases |
| 07/27/2006 | WO2006078318A2 Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae |
| 07/27/2006 | WO2006078307A1 Fixed dosing of her antibodies |
| 07/27/2006 | WO2006078272A2 Rhabdoviral n-fusion proteins as carrier for foreign antigens |
| 07/27/2006 | WO2006078271A2 Cloning and expression of the full length 110 kda antigen of orientia tsutsugamushi to be used as a vaccine component against scrub typhus |
| 07/27/2006 | WO2006078268A2 A peptide that elicits neutralizing antibodies targeting the hiv co-receptor, ccr5 |
| 07/27/2006 | WO2006078213A1 Vaccine composition comprisinga fibronectin binding protein or a fibronectin binding peptide |
| 07/27/2006 | WO2006078161A1 Binding compounds, immunogenic compounds and peptidomimetics |
| 07/27/2006 | WO2006078059A1 Emulsified composition for dilution and cancer vaccine composition |
| 07/27/2006 | WO2006077941A1 Cancer vaccine |
| 07/27/2006 | WO2006077724A1 Cancer vaccine preparation |
| 07/27/2006 | WO2006077614A1 Hmgb1 inhibitors and antagonists for the inhibition of atherosclerosis pathogenesis and development |
| 07/27/2006 | WO2006077592A2 Therapeutic transplantation using developing, human or porcine, renal or hepatic, grafts |
| 07/27/2006 | WO2006077466A2 Pen shaped medication injection devices |
| 07/27/2006 | WO2006077456A1 Oral administration of therapeutic agent coupled to transporting agent |
| 07/27/2006 | WO2006077442A2 Inhibition of islet amyloid polypeptide (iapp) aggregation for the treatment of type 2 diabetes |
| 07/27/2006 | WO2006077428A1 Pharmaceutical compounds |
| 07/27/2006 | WO2006077424A1 Pharmaceutical compounds |
| 07/27/2006 | WO2006077397A2 Method of producing conjugate vaccines |